Concepedia

Renee Emkey

RE

Statistics

Publications

31

Citations

1.8K

H-Index

23

Active since

1991

Affiliations

Amgen (United States)(Current)

Eli Lilly (United States)

Joslin Diabetes Center

Harvard University

Tufts University

Renee Emkey is an author at Amgen (United States) specializing in life sciences, pharmacology, and molecular biology.

Publications per year

1991–2016

31

Publications

31

Ral‐GTPases mediate a distinct downstream signaling pathway from Ras that facilitates cellular transformation.

Takeshi Urano, Renee Emkey, Larry A. Feig · The EMBO Journal · 1996 · 332 citations · Full text

, , +12

Dynamics of Insulin Signaling in 3T3-L1 Adipocytes

Gen Inoue, Bentley Cheatham, Renee Emkey et al. · Journal of Biological Chemistry · 1998 · 169 citations · Full text

, , +17

Metabotropic glutamate 2 receptor potentiators: receptor modulation, frequency-dependent synaptic activity, and efficacy in preclinical anxiety and psychosis model(s)

Michael P. Johnson, David A. Barda, Thomas C. Britton et al. · Psychopharmacology · 2005 · 154 citations

, , +17

Insulin Receptor Substrate 3 (IRS-3) and IRS-4 Impair IRS-1- and IRS-2-Mediated Signaling

Kaku Tsuruzoe, Renee Emkey, Kristina M. Kriauciunas et al. · Molecular and Cellular Biology · 2001 · 113 citations · Full text

, , +17

Identification and Pharmacological Profile of a New Class of Selective Nicotinic Acetylcholine Receptor Potentiators

Lisa M. Broad, Ruud Zwart, Kathy H. Pearson et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 86 citations

, , +17

1–5 of 31